
Compared to gene therapy Argus II is less costly with a demonstrated favorable outcome, though the vision is yet artificial.

Over the past few years, visual prostheses (namely, Argus II retinal implant) and gene therapy have obtained FDA approval in treating blindness resulting from retinitis pigmentosa.


1Department of Ophthalmology, Poostchi Ophthalmology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.Hossein Nowroozzadeh 1 †, Feisal Rahat 2 †, Hossein Peyvandi 3 †, Reza Farvardin 4 and Mohammad Nami 5,6 * Mohsen Farvardin 1,2, Mehrdad Afarid 1 †, Adel Attarzadeh 2 †, Mohammad K.
